Business context and reporting period
The filing is a Form 10-K for Ambac Financial Group, Inc. and subsidiaries for the fiscal year ended December 31, 2017; the source text does not identify Octave Specialty Group Inc. as the registrant. Ambac is a financial-services holding company whose principal subsidiaries, Ambac Assurance Corporation and Ambac Assurance UK Limited, provide financial-guarantee insurance and have been in runoff since 2008. The company reported one financial-guarantee segment beginning in the second quarter of 2017.
Ambac’s strategy is to manage the runoff through commutations, settlements, restructurings, loss recoveries, investment management and liability rationalization. The Segregated Account remained in rehabilitation at year-end but exited rehabilitation on February 12, 2018, after the Second Amended Plan of Rehabilitation became effective.
Key financial metrics
| Metric | 2017 | 2016 | Change or commentary |
|---|---|---|---|
| Net premiums earned | $175.3 million | $197.3 million | Down 11.2%; runoff reduced recurring premiums |
| Net investment income | $361.0 million | $313.4 million | Up $47.5 million, primarily from higher-yielding Ambac-insured securities |
| Total revenues | $621.2 million | $506.1 million | Higher investment income and derivative gains |
| Losses and loss expenses | $513.2 million | $(11.5) million benefit | Adverse development, primarily Puerto Rico and domestic public finance |
| Pre-tax income (loss) | $(284.3) million | $105.0 million | Material deterioration |
| Net income (loss) attributable to common shareholders | $(328.7) million | $74.8 million | Basic and diluted loss per share of $(7.25) |
| Adjusted earnings (non-GAAP) | $(165.1) million | $314.8 million | Excludes selected non-economic and accounting items |
| Cash flow from operating activities | $(212.8) million | $843.5 million | 2016 benefited from substantial litigation recoveries |
| Cash flow from investing activities | $928.8 million | $(714.6) million | Included significant portfolio sales and maturities |
| Cash and cash equivalents | $623.7 million | $91.0 million | Year-end cash increased substantially |
| Total investments, excluding VIE investments | $5.74 billion | $6.50 billion | Portfolio reduced through sales, maturities and restructuring activity |
| Total assets | $23.19 billion | $22.64 billion | Higher consolidated VIE assets |
| Total stockholders’ equity | $1.65 billion | $1.98 billion | Declined primarily due to comprehensive loss |
| Long-term debt, excluding VIE debt | $991.7 million | $1.11 billion | Reduced through debt extinguishments and amortization |
| Loss and loss expense reserves, net of subrogation recoverables and before reinsurance | $4.11 billion | $3.70 billion | Increased $417.8 million |
Material changes versus the prior comparable period
- Net guaranteed par outstanding declined 21% to $62.7 billion from $79.3 billion. Adversely classified exposure declined 17% to $14.1 billion, while watch-list exposure was $11.1 billion at year-end.
- Domestic public-finance losses were $476.3 million, substantially affected by Puerto Rico and military-housing exposures. Puerto Rico net par exposure was approximately $2.0 billion, with approximately $9.5 billion of net insured lifetime debt service outstanding.
- Ambac recorded a $91.6 million 2017 benefit from the Ballantyne/J.P. Morgan Investment Management settlement; the benefit reduced expected future claims and was not a direct cash receipt by Ambac UK.
- Ambac paid approximately $94.4 million to commute the Augusta interest-rate swaps and recorded an approximately $43.4 million gain. Total net gains on interest-rate derivatives were $59.6 million, compared with a $50.3 million loss in 2016.
- The last investment agreement matured in March 2017. The company also significantly reduced its remaining financial-services activities and now reports one segment.
- The investment portfolio became more concentrated in lower-rated and Ambac-insured assets. Below-investment-grade guaranteed exposure represented 22% of total net par at year-end, compared with 21% in 2016.
- Ambac’s statutory policyholder surplus declined to $699.6 million from $976.5 million. Ambac Assurance remained subject to regulatory restrictions and was not expected to pay dividends to the parent.
Guidance, outlook, commentary, risks and unusual items
Management did not provide conventional earnings or revenue guidance. The outlook is for continued runoff, active remediation of watch-list and adversely classified credits, litigation-driven recoveries, capital and liability restructuring, and selective evaluation of adjacent business opportunities. Any new-business strategy remains speculative and depends on available capital, regulatory approvals and execution.
- Rehabilitation exit and subsequent financing: On February 12, 2018, holders of Deferred Amounts generally received $0.40 of cash, $0.41 of new Secured Notes and, for certain surplus-note holders, $0.125 of existing surplus notes for each $1.00 of claim value, implying a $0.065 discount. Ambac received $0.91 of Secured Notes per $1.00 of its Deferred Amounts. The transactions required approximately $1.4 billion of cash outflow and materially changed the company’s capital structure.
- New debt: Ambac Assurance issued $240 million of Tier 2 Notes secured by certain RMBS litigation recoveries above $1.6 billion. The Ambac Note and related Secured Notes accrue interest at three-month U.S. dollar LIBOR plus 5%, subject to a 1% floor, and are primarily secured by RMBS litigation recoveries.
- Reserve uncertainty: Recorded representation-and-warranty subrogation recoveries were $1.81 billion net of reinsurance. If these recoveries were not realized, stockholders’ equity would fall from $1.65 billion to approximately negative $161.4 million. Management estimated possible adverse reserve changes of approximately $1.5 billion for public-finance credits, $1.9 billion for RMBS if recoveries were unavailable, $100 million for student loans and $250 million for other credits including Ambac UK; actual losses could exceed these estimates.
- Puerto Rico: PROMESA Title III proceedings, payment moratoria, the fiscal condition of Puerto Rico, Hurricanes Irma and Maria, litigation and uncertain federal aid create substantial uncertainty regarding claim payments and recoveries. A 2017 court decision in related litigation may limit Ambac’s ability to compel payment of pledged revenues.
- Liquidity and dividends: Parent-company liquidity depends primarily on cash and liquid investments, expense reimbursements and future tolling payments. Ambac Assurance dividends have been unavailable since 2008 without regulatory consent, and future tolling payments are uncertain. Parent-company liquid cash and investments available for general liquidity were approximately $96.3 million at year-end.
- Regulatory capital: Ambac UK reported a Solvency II capital-resource deficit of approximately £288.5 million at December 31, 2017. The PRA and FCA were aware of the deficiency and discussions were ongoing.
- Litigation and contingencies: The company is involved in Puerto Rico, RMBS, military-housing and student-loan litigation. Management states that probable and reasonably estimable litigation accruals were not material, but adverse outcomes could materially affect earnings, capital or liquidity.
- Tax matters: Ambac reported approximately $3.7 billion of U.S. federal NOL carryforwards and maintains a full valuation allowance against domestic deferred tax assets. The Tax Cuts and Jobs Act reduced the expected maximum annual tolling payment from Ambac Assurance to approximately $56 million from $97 million.
Most important facts an investor should verify
- Confirm the registrant identity: the supplied filing is Ambac Financial Group, Inc., not Octave Specialty Group Inc.
- Review the February 2018 Rehabilitation Exit Transactions, including the approximately $1.4 billion cash outflow, new Secured Notes, $240 million Tier 2 Notes and resulting post-transaction liquidity.
- Assess the probability and timing of the $1.81 billion of estimated RMBS representation-and-warranty recoveries.
- Evaluate Puerto Rico’s restructuring outcomes, legal decisions, federal aid and the potential effect on Ambac’s approximately $2.0 billion of net par exposure.
- Compare parent-company liquidity with scheduled operating expenses, debt service, claim payments and restricted access to subsidiary cash.
- Review Ambac Assurance’s statutory surplus, OCI approval requirements, surplus-note payment restrictions and Ambac UK’s Solvency II deficit.
- Consider the effect of runoff, adverse selection, below-investment-grade concentration, interest rates, credit spreads, foreign exchange and derivative termination rights on future earnings and capital.